Journals
2015 EN
Maria Theresa Alera · Laura Hermann · Ilya A. Tac-An
+13 more
To the Editor: Zika virus (ZIKV), a mosquitoborne flavivirus, was first isolated from a rhesus monkey in Uganda in 1947 (1). This positive-sense, single-stranded RNA virus (family Flaviviridae, genus Flavivirus) has a 10,794-nt genome and is most closely related to Spondweni virus (2,3). Phylogenetic analyses have revealed 2 major lineages: Asian and African (2–4). The first human infection with ZIKV was reported in Nigeria in 1954 (5). The virus caused only sporadic infections until 2007, when a large outbreak occurred on Yap, an island in the Federated States of Micronesia (6). In October 2013, ZIKV was detected in French Polynesia; since then, >400 laboratory-confirmed cases have been reported (7). ZIKV has spread across the South Pacific, and autochthonous cases have been reported in New Caledonia, Easter Island, and the Cook Islands. Several cases of ZIKV infections have been reported in travelers to Southeast Asia (4,8) and French Polynesia (3,7). In March 2012, a prospective longitudinal cohort study, which included active surveillance for acute febrile illness, was initiated in Cebu City, Philippines (I. Yoon, unpub. data). Participants contacted study staff to report fever and were also contacted weekly by staff to determine if they had fever during the previous 7 days. Fever episodes triggered an acute-illness visit by a study nurse, who performed a clinical assessment of the patient and collected an acute-phase blood sample. During the first year of surveillance, 270 acute febrile illnesses were detected; 267 of the patients had samples available for serologic testing for evidence of influenza, dengue, chikungunya, Japanese encephalitis, and Zika virus infections. In May 2012, a 15-year-old boy in Cebu City reported a subjective fever; an acute-illness investigation followed. Other symptoms included headache, conjunctivitis, sore throat, myalgias, stomach pain, anorexia, nausea, and vomiting, but no rash. The boy did not seek medical care or require hospitalization; his only treatment was acetaminophen. He had no recent travel history, and no other members of his household were ill. The boy recovered fully by the 3-week study follow-up visit. An acute-phase blood sample, collected 2 days after symptom onset, was negative for dengue and chikungunya viruses by reverse transcription PCR. An in-house dengue/Japanese encephalitis IgM/IgG capture ELISA and chikungunya ELISA were used to test paired acute- and convalescent-phase blood samples; all results were negative. ZIKV ELISA was not available at the testing laboratory. However, by using real-time reverse transcription PCR targeting the gene that encodes the precursor of membrane protein, we detected ZIKV RNA in the patient’s serum sample (6). Virus was then isolated by intrathoracically inoculating Toxorhynchites splendens mosquitoes and by inoculating C6/36 cells with patient serum. The MiSeq platform (Illumina, Hayward, CA, USA) was used to obtain sequence reads by next-generation genomic sequencing, which identified a 789-bp contig as a partial sequence of the ZIKV gene that encodes the nonstructural 5 protein (GenBank accession no. {"type":"entrez-nucleotide","attrs":{"text":"KM851038","term_id":"822599142","term_text":"KM851038"}}KM851038). Maximum-likelihood phylogenetic analysis of the gene encoding the nonstructural 5 protein sequence showed that the isolate belonged to the ZIKV Asian lineage (Figure). Pair-wise genetic distance calculation indicated that the isolate was most closely related to the 2007 strain from Micronesia (p-distance = 0.013), with which it shared ≈99% nt (779/789) similarity. Figure Maximum-likelihood phylogenetic tree of fragments of Zika virus was determined using the general time-reversible plus gamma distribution plus invariable site model with 13 reference Zika virus strains from GenBank. The contig sequence, obtained from de ... During the past decade, ZIKV has caused 2 large epidemics in Micronesia and French Polynesia. The virus has a high potential for ongoing geographic expansion into countries where Aedes spp. mosquitoes are present and are known to transmit ZIKV; most notable among these vectors are A. aegypti mosquitoes, which are widespread throughout the Philippines (9). ZIKV infections have been reported in travelers to areas in the South Pacific with known ZIKV transmission and to areas such as Thailand (4) and Indonesia (8), where no recent endemic cases have been described. However, a case of endemic ZIKV infection has been reported in a child in Cambodia, and serologic evidence of ZIKV infection has been reported in Thailand, Vietnam, Malaysia, Indonesia, and the Philippines (2). Phylogenetic analysis of the isolate from our study indicated that it is more closely related to the strain from Micronesia that was responsible for the 2007 Yap outbreak than to strains identified in Cambodia (2010), Thailand (2013), or French Polynesia (2013). It is possible that the ZIKV infection in our study was an isolated case (the virus was confirmed in only 1/270 episodes of acute febrile illness). However, because the symptoms of disease are similar to those for other known endemic arboviruses, it is also possible that the strain was introduced into the Philippines before 2012 and remained undetected. The spectrum of ZIKV-associated clinical disease remains uncertain. Although reports indicate most cases of infection are mild, infections may be associated with more severe disease outcomes, such as Guillain-Barre syndrome (10). Increased surveillance for ZIKV disease, using pan-flavivirus or ZIKV-specific molecular testing, may lead to more frequent identification of cases, which could give a clearer indication of the true number of ZIKV infections. Additional surveillance and research studies are needed to improve our understanding of this disease, including the potential epidemiologic and clinical effects of ZIKV co-circulation with other flaviviruses.
Centers for Disease Control and Prevention
Journals
2015 EN
Maïté Aubry · Anita Teissier · Claudine Roche
+8 more
To the Editor: Chikungunya virus (CHIKV), an arthropod-borne virus (arbovirus) of the family Togaviridae, genus Alphavirus, is transmitted by mosquitoes of the Aedes genus, especially Ae. aegypti and Ae. albopictus (1). The main clinical manifestations of CHIKV infections are sudden high fever, headache, back pain, myalgia, arthralgia affecting mainly the extremities, and rash. CHIKV emerged in the Pacific region in New Caledonia in March 2011. Additional outbreaks occurred in Papua New Guinea in June 2012; Yap State (Federated States of Micronesia) in August 2013; Tonga in April 2014; and American Samoa, Samoa, and Tokelau in July 2014 (2). Phylogenetic analysis of CHIKV strains showed the existence of 3 lineages: West African, Asian, and East/Central/South African (1). French Polynesia is a French territory in the South Pacific, with 270,000 inhabitants living on 5 archipelagoes. Arboviruses are a common cause of outbreaks in French Polynesia: the last dengue virus (DENV) outbreaks caused by DENV-1 and DENV-3 occurred in 2013 (3), and DENV-1 still circulates. French Polynesia also experienced the largest Zika virus (ZIKV) outbreak ever reported during October 2013–April 2014 (4). In May 2014, CHIKV infection was detected for the first time in French Polynesia in a traveler returning from Guadeloupe, (5) where a chikungunya outbreak was ongoing (6). In late September 2014, an increasing number of patients with fever and rash who tested negative for DENV and ZIKV by real-time reverse transcription PCR (RT-PCR) were recorded by the French Polynesia Department of Health on the south coast of Tahiti, French Polynesia’s main island. Serum samples collected from 19 of these patients were tested for CHIKV by RT-PCR using previously reported primers and a probe (7). Seven of the 19 (37%) were positive; all 7 were autochthonous. The first specimen that tested positive for CHIKV had been collected from a patient on September 25, and by October 25, a total of 318 patients were confirmed by RT-PCR to be infected by CHIKV. Nearly all districts of Tahiti were affected, and cases were reported on 4 of French Polynesia’s 5 archipelagoes. Partial sequencing of the CHIKV E1 gene of a strain isolated from a patient and collected on September 29 (strain PF14-290914-16, GenBank accession no. {"type":"entrez-nucleotide","attrs":{"text":"KM985619","term_id":"807059694","term_text":"KM985619"}}KM985619) was performed as previously reported (8). Phylogenetic analysis showed that French Polynesia’s CHIKV strain belongs to the Asian lineage and is more closely related to a strain collected in the British Virgin Islands in 2014 (VG14/99659) and to the French Polynesian strain imported from Guadeloupe in May 2014 (PF14-270514-51impGP), with 99.9% homology, than to the strains that recently circulated in Yap State (FM13/3807), Tonga (TO14-080414-3007 and TO14-080414-3042), and New Caledonia (NC11-568) (Figure). Figure Phylogenetic analysis of chikungunya virus strain isolated in French Polynesia on September 29, 2014. The evolutionary history was inferred by using the maximum-likelihood method based on the Kimura 2-parameter model. The percentage of trees in which ... No cases of CHIKV infection were reported in French Polynesia within the 4 months after the imported case detected on May 25, 2014. Because of the active, ongoing circulation of CHIKV in the Pacific, introduction of this virus in French Polynesia was expected from other Pacific islands, especially from New Caledonia, because of extensive travel between the 2 French territories. The fact that the CHIKV strain circulating in French Polynesia is closely related to the strains currently circulating in the Caribbean suggests that the French Polynesia outbreak is a result of the introduction of CHIKV from the Caribbean rather than from another Pacific island. The delay between the current outbreak and the first infected patient detected in 2014 also suggests a new introduction rather than a circulation of the strain introduced in May. However, an undetected low-level circulation of CHIKV during the cooler and drier low transmission season, simultaneously with DENV-1 circulation, cannot be excluded. The introduction of arboviruses into French Polynesia from other French overseas territories rather than from other Pacific islands was previously reported for DENV. In 2013, DENV-3 reappeared in French Polynesia 3 months after the Solomon Islands had declared a DENV-3 outbreak. However, epidemiologic and phylogenetic investigations revealed that the DENV-3 strain that caused the outbreak in French Polynesia had been introduced by a traveler returning from French Guiana and belonged to a different genotype than the one that was circulating in the Solomon Islands (3). Several conditions are favorable to a large chikungunya outbreak in French Polynesia. First, because CHIKV has never been previously reported in French Polynesia, the entire population is thought to be immunologically naive for CHIKV infection. Second, 2 potential vectors for CHIKV are present in French Polynesia: Ae. aegypti (1) and Ae. polynesiensis mosquitoes (9). Third, in French Polynesia the hot and rainy season that lasts from October through March is conducive to the proliferation of mosquitoes. We have the experience of the French Polynesian ZIKV outbreak that started with the same favorable conditions in October 2013 and was responsible for 28,000 estimated symptomatic cases from October 2013 through April 2014 (10). This new outbreak corroborates the recent observation that the expansion of arboviruses in the Pacific is ongoing and inevitable (2).
Centers for Disease Control and Prevention
Journals
2015 EN
Ghyslain MomboNgoma · Jean Rodolphe Mackanga · Arti Basra
+11 more
Loa loa, the African eye worm, is a filarial pathogen of Central African rainforest regions. As of 2013, it had affected an estimated 2–3 million persons in Central Africa (1,2). Adult worm migrations in humans may intermittently cause Calabar swelling, and microfilariae are commonly found in blood and body fluids. Loiasis is a chronic infection persisting for many years; a considerable proportion of women in loiasis-endemic regions are infected during gestation. To date, the epidemiology of loiasis in pregnant women has not been investigated, and the effects of loiasis on maternal and fetal health outcomes are unknown. We investigated the epidemiology of loiasis in a cohort of pregnant women participating in a drug trial for preventing malaria during pregnancy
Centers for Disease Control and Prevention
Journals
2015 EN
Maria Glória Teixeira · Alcina M.S. Andrade · Maria da Conceição Nascimento Costa
+7 more
To the Editor: Chikungunya virus (CHIKV) is an arthropod-borne alphavirus (family Togaviridae) comprising 3 genotypes: West African, East/Central/South African, and Asian (1). This zoonotic pathogen originated in Africa and since 2004 has caused outbreaks in several countries on different continents (2). In 2013, CHIKV reached the Americas and caused an explosive epidemic that has already caused 1,231,077 cases in 43 countries (3). In Brazil, autochthonous cases of chikungunya were confirmed in September 2014 in Feira de Santana (FSA), a city of 612,000 residents (4) near the eastern edge of Bahia State in east-central Brazil. Surprisingly, the CHIKV genotype was determined to be East/Central/South African and not the Asian genotype that is circulating in the Americas; this finding was based on sequence data obtained from a cell culture viral isolate using an Ion Torrent platform (3,5). Dengue is endemic/epidemic to FSA, and the first cases of chikungunya were mistakenly reported as dengue. Beginning in July 2014, when dengue virus transmission is low, an increased number of suspected cases of dengue from a FSA neighborhood caught the attention of local surveillance officials. CHIKV infection was suspected because results of laboratory tests for dengue (nonstructural 1 and IgM ELISA) were negative, and the patients complained mainly of high fever and intense bilateral joint pain accompanied by swelling (4). IgM ELISA and quantitative reverse transcription PCR conducted at the Instituto Evandro Chagas (Ananindeua, Brazil) confirmed the cause of illness as CHIKV. The sequences obtained in this study were deposited in the GenBank under accession nos. {"type":"entrez-nucleotide-range","attrs":{"text":"KP164567-KP164572","start_term":"KP164567","end_term":"KP164572","start_term_id":"777861422","end_term_id":"777861512"}}KP164567-KP164572. Data from epidemiologic investigations suggested that the index case-patient could have been a Brazilian citizen living in Luanda, Angola, who visited his family in FSA. He went to an emergency health unit in FSA on May 28, reporting intense joint pain and high fever. His laboratory tests (nonstructural 1 and IgM) for dengue were negative. On June 4 (epidemiologic week [EW] 23), another person sought care for similar symptoms, and new cases emerged, all in residents in that same neighborhood (4).The epidemic peaked in EW 39, when 200 cases were reported. Cases then decreased, and in EW 48 only 10 cases were reported (Figure). Figure Reported cases of chikungunya fever, by epidemiologic week. Feira de Santana, Bahia State, Brazil, 2014. In FSA, of the 1,346 chikungunya cases (219.9/100,000 residents) reported through EW 48, a total of 52.4% (1,498.1/100,000) patients lived in the same neighborhood as the index patient. However, the other 77 neighborhoods in FSA also recorded cases. Twice as many cases occurred among female patients (67.1% of cases) as among male patients. All age groups were affected; incidence was highest in persons 20–49 years of age (56.2%; 267.1 cases/100,000 inhabitants). The main clinical manifestations were high fever, arthralgia and arthritis with edema, headache, myalgia, rash, and itching. As of EW 48, no deaths were recorded (4). CHIKV is transmitted by Aedes aegypti and Ae. albopictus mosquitoes, but FSA has Ae. aegypti only, and the Premise Index was 1.1% on January 2014 (6). Thus, during EW 36, the surveillance service of FSA began intense actions to combat that vector (5) by using integrated environmental management (7): elimination of breeding sites, applications of larvicide in water bodies, spraying insecticide (ultra-low volume), mobilization, and community education. However, cases continued to be diagnosed in neighborhoods in FSA, and transmission was detected in another municipality 77 km from FSA (391 cases through EW 48). Isolated cases imported from FSA were detected in other municipalities of Bahia State (8). This epidemic had some unusual aspects. First, it was not caused by the Asian genotype circulating in affected countries of the Americas, which maintain intense tourism and trade with Brazil. Second, it occurred during the dry season, when little dengue transmission was occurring. The introduction of a person from a country reporting CHIKV activity (9) into an area infested by Ae. aegypti mosquitoes and having a population immunologically naive to CHIKV created favorable conditions to establish a local transmission cycle with quick production of many cases. Concurrently with the outbreak in FSA, chikungunya cases were detected in Oiapoque municipality (10), Amapa State (northern Brazil bordering French Guiana); these cases were caused by the Asian genotype (genotype determined by nearly complete genome sequencing using an Ion Torrent sequencer). The picture so far suggests that expansion of the epidemic to other places in Brazil can be caused both by internal movement of persons and by new cases imported from other countries. Chikungunya fever is a health problem that threatens Brazilian society and poses a challenge for health authorities. CHIKV produces epidemics of great magnitude, is highly debilitating, and does not have any specific treatment or vaccine. This situation is creating serious social and economic consequences for low- and middle-income countries because of the excessive demand on health services and the social security programs used by much of the population. Therefore, the global spread of chikungunya fever highlights the need to mobilize national and international efforts to focus scientific research on developing tools to prevent this disease.
Centers for Disease Control and Prevention
Journals
2015 EN
Domenico Otranto · Alessio Giannelli · Maria Stefanía Latrofa
+6 more
Infections with Onchocerca lupi nematodes are diagnosed sporadically in the United States. We report 8 cases of canine onchocercosis in Minnesota, New Mexico, Colorado, and Florida. Identification of 1 cytochrome c oxidase subunit 1 gene haplotype identical to 1 of 5 from Europe suggests recent introduction of this nematode into the United States.
Centers for Disease Control and Prevention
Journals
2015 EN
Jan W. M. van der Linden · Maiken Cavling Arendrup · Adilia Warris
+24 more
To investigate azole resistance in clinical Aspergillus isolates, we conducted prospective multicenter international surveillance. A total of 3,788 Aspergillus isolates were screened in 22 centers from 19 countries. Azole-resistant A. fumigatus was more frequently found (3.2% prevalence) than previously acknowledged, causing resistant invasive and noninvasive aspergillosis and severely compromising clinical use of azoles.
Centers for Disease Control and Prevention
Journals
2015 EN
Antonio Piralla · Ana Moreno · Maria Ester Orlandi
+4 more
Because swine influenza virus infection is seldom diagnosed in humans, its frequency might be underestimated. We report a immunocompromised hematologic patient with swine influenza A(H3N2) virus in 2014 in Italy. Local pigs were the source of this human infection.
Centers for Disease Control and Prevention
Journals
2015 EN
Antonietta Filia · Antonino Bella · Giovanna Cadeddu
+6 more
We report a measles outbreak in Sardinia, Italy, that originated in a cruise ship passenger. The outbreak showed extensive nosocomial transmission (44 of 80 cases). To minimize nosocomial transmission, health care facilities should ensure that susceptible health care workers are vaccinated against measles and should implement effective infection control procedures.
Centers for Disease Control and Prevention
Journals
2015 EN
Tyler M. Sharp · Rosa Moreira · Maria José Soares
+9 more
During the 2013 dengue epidemic in Luanda, Angola, 811 dengue rapid diagnostic test-positive cases were reported to the Ministry of Health. To better understand the magnitude of the epidemic and identify risk factors for dengue virus (DENV) infection, we conducted cluster surveys around households of case-patients and randomly selected households 6 weeks after the peak of the epidemic. Of 173 case cluster participants, 16 (9%) exhibited evidence of recent DENV infection. Of 247 random cluster participants, 25 (10%) had evidence of recent DENV infection. Of 13 recently infected participants who had a recent febrile illness, 7 (54%) had sought medical care, and 1 (14%) was hospitalized with symptoms consistent with severe dengue; however, none received a diagnosis of dengue. Behavior associated with protection from DENV infection included recent use of mosquito repellent or a bed net. These findings suggest that the 2013 dengue epidemic was larger than indicated by passive surveillance data.
Centers for Disease Control and Prevention
Journals
2015 EN
Albert J. Auguste · Jonathan Liria · Naomi L. Forrester
+11 more
In 2010, an outbreak of febrile illness with arthralgic manifestations was detected at La Estación village, Portuguesa State, Venezuela. The etiologic agent was determined to be Mayaro virus (MAYV), a reemerging South American alphavirus. A total of 77 cases was reported and 19 were confirmed as seropositive. MAYV was isolated from acute-phase serum samples from 6 symptomatic patients. We sequenced 27 complete genomes representing the full spectrum of MAYV genetic diversity, which facilitated detection of a new genotype, designated N. Phylogenetic analysis of genomic sequences indicated that etiologic strains from Venezuela belong to genotype D. Results indicate that MAYV is highly conserved genetically, showing ≈17% nucleotide divergence across all 3 genotypes and 4% among genotype D strains in the most variable genes. Coalescent analyses suggested genotypes D and L diverged ≈150 years ago and genotype diverged N ≈250 years ago. This virus commonly infects persons residing near enzootic transmission foci because of anthropogenic incursions.
Centers for Disease Control and Prevention